Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

2.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.04

Target Price

6

Analyst Recom

2

Performance Q

-1.45

Relative Volume

Beta

2.88

Ticker: MURA



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09MURA2.040.26999.9925116
2025-12-10MURA2.040.26999.9925116
2025-12-11MURA2.040.26999.9925116
2025-12-12MURA2.04N/AN/A0
2025-12-15MURA2.04N/AN/A0
2025-12-16MURA2.04N/AN/A0
2025-12-17MURA2.04N/AN/A0
2025-12-18MURA2.04N/AN/A0
2025-12-19MURA2.04N/AN/A0
2025-12-22MURA2.04N/AN/A0
2025-12-23MURA2.04N/AN/A0
2025-12-26MURA2.04N/AN/A0
2025-12-29MURA2.04N/AN/A0
2025-12-30MURA2.04N/AN/A0
2025-12-31MURA2.04N/AN/A0
2026-01-02MURA2.04N/AN/A0
2026-01-05MURA2.04N/AN/A0
2026-01-06MURA2.04N/AN/A0
2026-01-07MURA2.04N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



5 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09MURA0.0081.6- -5.66
2025-12-10MURA2.0481.6- -5.66
2025-12-11MURA2.0481.6- -5.66
2025-12-12MURA2.04- - -
2025-12-15MURA2.04- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
5 items Current Page1 of 1



9 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-09MURA-2.03-16.452.62
2025-12-10MURA-2.03-16.452.72
2025-12-11MURA-2.03-16.452.66
2025-12-12MURA-2.62-16.452.66
2025-12-15MURA-2.62-16.452.66
2025-12-16MURA-2.62-16.452.66
2025-12-17MURA-2.62-16.452.66
2025-12-18MURA-2.62-16.452.66
2025-12-19MURA-2.62-16.452.66
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
9 items Current Page1 of 1

Last Quarter Act. EPS​

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.62

Institutional Transactions

-16.45

Beta

2.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

Sentiment Score

78

Actual DrawDown %

88

Max Drawdown 5-Year %

Target Price

6

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.8

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Mural Oncology plc
Sector: Healthcare
Industry: Biotechnology
Employees: 116
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland. As of December 4, 2025, Mural Oncology plc operates as a subsidiary of XOMA Royalty Corporation.
stock quote shares MURA – Mural Oncology plc Stock Price stock today
news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025
marketwatch MURA – Mural Oncology plc yahoo finance google finance
stock history MURA – Mural Oncology plc invest stock market
stock prices MURA premarket after hours
ticker MURA fair value insiders trading